Meiji Holdings Co (2269) AI Stock Analysis

• Market Cap: ¥972.82B
• Dividend Yield: 2.96%
• Average Volume (3M): 2.77M
• Price to Earnings (P/E): 21.1
• Beta (1Y): 0.03
• Revenue Growth: 2.79%
• EPS Growth: -6.46%
• Country: JP
• Employees: 17,270
• Sector: Consumer Defensive
• Sector Strength: 42
• Industry: Packaged Foods
• EPS (TTM): 42.00
• Shares Outstanding: 282,200,000
• 10 Day Avg. Volume: 1,647,740
• 30 Day Avg. Volume: 2,774,413
• PEG Ratio: 7.15
• Price to Book (P/B): 1.19
• Price to Sales (P/S): 0.77
• P/FCF Ratio: 54.83
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 74 Outperform
• Price Target: ¥3,787.00 ▲(24.86% Upside)

The stock's overall score is driven by strong financial performance and positive technical indicators. The valuation is reasonable, but not exceptional. The lack of earnings call and corporate events data means these factors do not influence the score.

Positive Factors

Revenue Growth

Consistent revenue growth indicates a stable demand for Meiji's products, reflecting its strong market position and effective business strategies.

Balance Sheet Health

A low debt-to-equity ratio suggests conservative financial management, providing Meiji with flexibility to invest in growth opportunities and withstand economic downturns.

Operational Efficiency

Stable gross profit margins reflect efficient operations and cost management, enabling Meiji to maintain profitability despite potential market fluctuations.

Negative Factors

Free Cash Flow Decline

A sharp decline in free cash flow growth suggests potential cash management issues, which could limit Meiji's ability to invest in future growth and innovation.

Net Profit Margin Pressure

Decreasing net profit margins may indicate rising costs or competitive pressures, which could affect Meiji's long-term profitability if not addressed.

Cash Generation Challenges

Moderate cash generation relative to net income highlights potential constraints in liquidity, which may impact Meiji's capacity to fund operations and strategic initiatives.

Meiji Holdings Co Business Overview & Revenue Model

Company Description

Meiji Holdings Co., Ltd. is a prominent Japanese company engaged in the food and pharmaceuticals sectors. Established in 1917, the company operates through two main divisions: the Food Division, which produces dairy products, confectionery, and processed foods, and the Pharmaceuticals Division, which focuses on prescription drugs, vaccines, and over-the-counter medications. Meiji is recognized for its commitment to quality and innovation, aiming to enhance the health and well-being of consumers through its diverse range of products.

How the Company Makes Money

Meiji Holdings generates revenue primarily through the sale of its food and pharmaceutical products. The Food Division is a key revenue driver, offering various dairy products such as milk, yogurt, and cheese, alongside confectionery items like chocolate and snacks. The Pharmaceuticals Division contributes significantly to earnings through the development and sale of prescription medications and vaccines. Additionally, Meiji engages in strategic partnerships with healthcare providers and distributors, enhancing its market reach and sales capabilities. The company also invests in research and development to innovate and expand its product offerings, thereby attracting a broader customer base and increasing its revenue potential.

Meiji Holdings Co Financial Statement Overview

Summary

Meiji Holdings Co demonstrates financial stability with strong equity and improving cash flow metrics. However, the decline in revenue growth is a concern. The company maintains stable profitability margins, indicating operational efficiency. Low debt levels and a strong equity position reduce financial risk.

Income Statement

Meiji Holdings Co shows a mixed performance in its income statement. The TTM data indicates a decline in revenue growth rate, which is concerning. However, the company maintains a stable gross profit margin of around 29.3% and a net profit margin of approximately 4.1%. The EBIT and EBITDA margins are also stable, indicating operational efficiency. Despite the revenue decline, the company has managed to keep its profitability metrics relatively stable.

Balance Sheet

The balance sheet of Meiji Holdings Co reflects a strong equity position with a low debt-to-equity ratio of 0.12 in the TTM period, indicating low financial leverage. The return on equity is modest at 6.3%, suggesting moderate profitability from shareholders' investments. The equity ratio is healthy, showing that a significant portion of the company's assets is financed by equity, which reduces financial risk.

Cash Flow

The cash flow statement reveals a significant improvement in free cash flow growth, which increased by 61.7% in the TTM period. The operating cash flow to net income ratio is 0.24, indicating that the company generates sufficient cash from operations relative to its net income. However, the free cash flow to net income ratio is lower at 0.37, suggesting that while cash flow is improving, there is room for better conversion of net income into free cash flow.

Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	1.16T	1.15T	1.11T	1.06T	1.01T	1.19T
Gross Profit	342.53B	339.10B	336.88B	306.80B	323.25B	449.63B
EBITDA	131.63B	137.84B	143.20B	149.46B	179.07B	152.23B
Net Income	45.41B	50.80B	50.67B	69.42B	87.50B	65.66B
Balance Sheet
Total Assets	1.23T	1.18T	1.21T	1.14T	1.12T	1.07T
Cash, Cash Equivalents and Short-Term Investments	69.90B	78.19B	106.86B	63.52B	67.41B	40.33B
Total Debt	100.42B	47.80B	49.93B	64.37B	81.27B	101.78B
Total Liabilities	440.05B	392.69B	417.50B	384.91B	404.44B	407.64B
Stockholders Equity	749.01B	748.29B	746.53B	711.91B	673.34B	621.43B
Cash Flow
Free Cash Flow	2.21B	16.18B	54.54B	12.84B	34.36B	55.78B
Operating Cash Flow	55.76B	68.98B	107.98B	85.01B	127.53B	123.68B
Investing Cash Flow	-67.39B	-40.64B	-24.60B	-36.79B	-27.61B	-93.11B
Financing Cash Flow	-6.66B	-61.67B	-43.77B	-54.73B	-77.00B	-28.29B

Meiji Holdings Co Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 3033.00
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:2269, the sentiment is Positive. The current price of 3033 is below the 20-day moving average (MA) of 3460.95, below the 50-day MA of 3294.49, and below the 200-day MA of 3178.09, indicating a bullish trend. The MACD of 66.40 indicates Positive momentum. The RSI at 69.37 is Neutral, neither overbought nor oversold. The STOCH value of 85.71 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:2269.

Meiji Holdings Co Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
2897	77 Outperform	¥858.86B	17.57	9.77%	2.41%	1.46%	-2.17%
2875	76 Outperform	¥1.09T	16.56	13.26%	1.82%	3.64%	5.31%
2269	74 Outperform	¥972.82B	21.13	5.97%	2.96%	2.79%	-6.46%
2871	72 Outperform	¥463.13B	17.69	9.86%	2.58%	1.08%	2.71%
2282	70 Outperform	¥664.34B	21.00	6.04%	2.04%	5.55%	27.03%
2002	70 Outperform	¥543.42B	22.76	―	3.15%	-0.88%	-25.64%
Sector *	62 Neutral	$20.33B	14.63	-3.31%	3.23%	1.93%	-12.26%

Meiji Holdings Co Corporate Events

Meiji Holdings Enhances Shareholder Benefit Program

Meiji Holdings Co., Ltd. has announced an enhancement to its Shareholder Benefit Program, aiming to deepen shareholder engagement and appreciation. The amendment introduces a Long-term Holding Appreciation BOX for shareholders holding shares for more than three years, in addition to existing benefits, thereby encouraging long-term investment and support.

The most recent analyst rating on (JP:2269) stock is a Hold with a Yen3564.00 price target. To see the full list of analyst forecasts on Meiji Holdings Co stock, see the JP:2269 Stock Forecast page.

Meiji Holdings Enhances Pharmaceutical Operations with Strategic Asset Transfer

Meiji Holdings Co., Ltd. announced a strategic move to transfer the common stock of its subsidiary, KM Biologics Co., Ltd., to Meiji Seika Pharma Co., Ltd. through an absorption-type company split. This decision is part of the company’s structural reforms to strengthen its pharmaceutical business foundation and enhance integrated operations. By aligning management policies and business strategies, Meiji aims to accelerate its global expansion and develop innovative pharmaceuticals, leveraging the combined expertise of its subsidiaries in infectious diseases. This move is expected to promote faster decision-making and create a more efficient supply system, reinforcing Meiji’s commitment to sustainable growth and social responsibility.

The most recent analyst rating on (JP:2269) stock is a Hold with a Yen3208.00 price target. To see the full list of analyst forecasts on Meiji Holdings Co stock, see the JP:2269 Stock Forecast page.

Meiji Holdings Reports Modest Sales Growth Amid Profit Decline

Meiji Holdings Co. reported a slight increase in net sales for the first half of the fiscal year ending March 2026, despite a decline in operating and ordinary profits. The company has added Meiji Food Asia Pacific Pte. Ltd. to its scope of consolidation, indicating a strategic expansion in the Asia Pacific market. The forecast for the full fiscal year shows an expected rise in net sales and profits, suggesting a positive outlook for the company’s future performance.

The most recent analyst rating on (JP:2269) stock is a Hold with a Yen3208.00 price target. To see the full list of analyst forecasts on Meiji Holdings Co stock, see the JP:2269 Stock Forecast page.

Meiji Holdings Launches Career Support Program for Senior Employees

Meiji Holdings Co., Ltd. has announced the implementation of the Next Career Special Support Program, aimed at supporting employees aged 50 and older with over 15 years of service in transitioning to new careers outside the company. This initiative is part of Meiji’s broader strategy to foster individual growth and organizational reform, aligning with its 2026 Medium-Term Business Plan. The program includes special allowances and reemployment support services, though its financial impact remains uncertain.

The most recent analyst rating on (JP:2269) stock is a Hold with a Yen3208.00 price target. To see the full list of analyst forecasts on Meiji Holdings Co stock, see the JP:2269 Stock Forecast page.